Autologous blood reinfusion during iatrogenic acute hemorrhagic cardiac tamponade: Safety and feasibility in a cohort of 30 patients

Catheter Cardiovasc Interv. 2019 Jan 1;93(1):E56-E62. doi: 10.1002/ccd.27784. Epub 2018 Sep 23.

Abstract

Background: Iatrogenic hemorrhagic pericardial tamponade (IHPT) represents a life-threating condition requiring emergency pericardiocentesis. In this clinical context, reinfusion of pericardial blood can stabilize the patient and sustain hemodynamic conditions.

Aims and methods: We reviewed all cases of IHPT occurred at our hospital over a 10 years span. In all patient autologous blood reinfusion through a femoral vein was performed.

Results: In our clinical experience of 30 consecutive patients with hemorrhagic cardiac tamponade, this technique was successful to limit blood transfusions, to prevent further clinical worsening and bridge patients with intractable bleeding, to cardiac surgery. No major adverse reactions were directly related to blood autotransfusion.

Conclusion: In the complex clinical scenario of acute tamponade occurring during catheter-based cardiac procedures, autotransfusion of pericardial blood through a femoral vein is safe and effective. It can be a useful trick up the sleeve of the interventional cardiologist.

Keywords: autologous pericardial blood transfusion; cardiac tamponade; coronary perforation; pericardiocentesis; resuscitation.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Blood Transfusion, Autologous* / adverse effects
  • Cardiac Catheterization / adverse effects*
  • Cardiac Tamponade / diagnostic imaging
  • Cardiac Tamponade / etiology
  • Cardiac Tamponade / therapy*
  • Feasibility Studies
  • Female
  • Femoral Vein*
  • Hemorrhage / diagnostic imaging
  • Hemorrhage / etiology
  • Hemorrhage / therapy*
  • Humans
  • Iatrogenic Disease*
  • Male
  • Middle Aged
  • Pericardiocentesis* / adverse effects
  • Retrospective Studies
  • Risk Factors
  • Treatment Outcome